Brief: Caribou Biosciences Expands Clinical Development Of CB-010 With FDA Clearance Of IND In Lupus

Caribou Biosciences

04/04/2024 21:28

April 4 (Reuters) - Caribou Biosciences Inc  CRBU.O :
    * CARIBOU BIOSCIENCES EXPANDS CLINICAL DEVELOPMENT OF CB-010
WITH
FDA CLEARANCE OF IND IN LUPUS

Source text for Eikon:  ID:nGNX6WBYjp 
Further company coverage:  CRBU.O 

 ((Reuters.Briefs@thomsonreuters.com;))